Women’s Health Module 
The following video interviews were recorded during the Southern Medical Association’s 19th Annual Conference on Focus on the Female Patient, July 20-24, 2008 in Kiawah Island, South Carolina.

Urinary Incontinence in Women
The purpose of this discussion is to prepare primary care physicians for the work-up and treatment of the various types of incontinence.

Support provided by Pfizer, Inc.

How to Survive and Deal with Fibromyalgia: Both You and Your Patient
This discussion will review recent insights into the pathophysiology and new drug approvals for fibromyalgia for more optimal management of these patients.

 
Support provided by Pfizer, Inc.

Headaches: Diagnosis and Management in a Busy Office Setting
The purpose of this presentation is to provide the general practitioner and specialist alike with a reliable system for managing headache patients. The discussion will include a brief review of headache classification, common pitfalls encountered during management, and a more detailed review of how and when particular abortive and prophylactic agents may be effectively used.

Support provided by Pfizer, Inc.

Hypertension, Diabetes and Hyperlipidemia Module 
The following video interviews were recorded during the Southern Medical Association’s 12th Annual Conference on Hypertension: A Focus on Hypertension, Diabetes, and Hyperlipidemia, July 18-20, 2008 in Savannah, Georgia.

Current Goals for Glucose Reduction in the Outpatient Setting: To What Goal and with What Medicines?
The purpose of this discussion is to review results from national trials and use the information to help clinicians develop a treatment protocol including the appropriate A1C goal for optimizing cardiovascular risk in those with diabetes.

Support provided by Merck & Co., Inc. and Pfizer, Inc.

Residual Risk after Statin-based LDL-C goals have been reached: How to Evaluate and How to Treat, a Focus on Chronic Kidney Disease
This discussion will talk about residual risk and how clinicians should approach these patients, including those with chronic kidney disease, once their LDL-Cholesterol is at goal.

Support provided by Merck & Co., Inc. and Pfizer, Inc.

Osteoporosis Module 
The following video selections were recorded during the Southern Medical Association’s 11th Annual Conference on Osteoporosis held February 21-24, 2008 in Amelia Island, Florida.

New NOF Guidelines
The purpose of this discussion is to briefly review the new guidelines, illustrate how they can be used to calculate the 10-year probability of sustaining a fracture, and help clarify some of the important issues pertaining to their use.

Hormonal Replacement Therapy
The purpose of this discussion is to provide guidance to clinicians about potential benefits and adverse effects, when to initiate therapy as well as the necessary precautions required to minimize the risk of adverse effects.

Support provided by Pfizer, Inc., & Wyeth Pharmaceuticals

Choosing a Bisphosphonate for the Management of Osteoporosis
The main purpose of this discussion is to help clinicians evaluate the efficacy and safety of the various FDA approved bisphosphonates.

Support provided by Pfizer, Inc. & Wyeth Pharmaceuticals